§ BIOTECHNOLOGY
USD · Biotechnology

GMAB

GENMAB A/S -SP ADR
USDSector · BiotechnologyBeta · 0.59
LAST · AS OF APR 10
28.25
−0.03 ▼ 0.11%PREV CLOSE · $28.28
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
OPEN 28.54HIGH 28.56LOW 28.1652W 1157.00 — 2257.00

§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY

13F FLOW
163 increased/new, 101 decreased/exited (13F)
AC 13F Analysis

§ 04 · FUNDAMENTALS · THE BOOKS

P/E18.1P/B3.35
EPS (TTM)15.42
§ 05 · WHO OWNS IT
Top institutional holders
All holders →
FundShares% portΔ Q/Q
Orbis Allan Gray Ltd12.9M1.5%−10%
ALLIANCEBERNSTEIN L.P.9.6M0.1%−12%
Paradigm Biocapital Advisors LP8.0M4.4%+13%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP5.0M0.1%−0%
BlackRock, Inc.4.5M0.0%−1%
Renaissance Technologies4.4M0.2%+26%
◇ AC INTELLIGENCE

Top institutional owners for GMAB as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.

§ 06 · WHO OWNS IT · BY STRATEGY

OTHER99.9% · 3 holders
OTHER0.0% · 210 holders
QUALITY / COMPOUNDER0.0% · 12 holders
SYSTEMATIC / QUANT0.0% · 11 holders
PASSIVE / INDEX0.0% · 7 holders
DEALER / BANK0.0% · 30 holders
TACTICAL / MACRO0.0% · 3 holders
◇ AC INTELLIGENCE

Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.

§ 07 · INSIDER ACTIVITY · LAST 180 DAYS

NO INSIDER FILINGS
◇ AC INTELLIGENCE

No Form 4 filings on record for GMAB in the last 180 days.

§ 08 · COVERAGE · OUR RECENT NOTES

No notes mention GMAB yet.